chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: FLU3, PPV, FLU3
Symptoms: Drooling, Headache, Hypoaesthesia
Clinical narrative: This medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 63 year-old male patient who had a medical history of hyperlipidemia, hypertension, benign prostatic hypertrophy, insomnia, GERD, prostatitis and obesity. Concurrent illnesses included prostate issues which were still ongoing. The patient had records from ER for visit related to abdominal pain. The patient had an annual visit requested spot on chest to be reviewed. On 03-Nov-2009, the patient reviewed AFLURIA (batch number "0867911A", dose 1) on the left arm and PNEUMOVAX (batch number 0632Y, dose 1) on the right arm. On 04-Nov-2009, the patient contacted the clinic complaining of pain in the back of head, numbness of face and drooling. The outcome was recovered.
Age: 69.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Headache, Pain
Clinical narrative: This non-serious medically confirmed health authority report (initial report 20-JUL-2015) concerns a 69 year old male patient. The patient had the influenza injection 13 other times at the medical centre without any noted problems. On the 15-Oct-2014, the patient received AFLURIA injection (batch number T50707) dose 1, via syringe in the left arm. On the 08-Dec-2014, the patient developed headache, sore ribs, sharp pain from the left flank to the left axillary and left breast and dull achy pains still ongoing two months after the injection. Outcome was recovered. Reporter comments: The regulator reported the case as non-serious.
Age: 69.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Axillary pain, Breast pain, Flank pain, Headache, Musculoskeletal chest pain
Clinical narrative: This non-serious medically confirmed health authority report (initial report 20-JUL-2015) concerns a 69 year old male patient. The patient had the influenza injection 13 other times at the medical centre without any noted problems. On the 15-Oct-2014, the patient received AFLURIA injection (batch number T50707) dose 1, via syringe in the left arm. On the 08-Dec-2014, the patient developed headache, sore ribs, sharp pain from the left flank to the left axillary and left breast and dull achy pains still ongoing two months after the injection. Outcome was recovered. Reporter comments: The regulator reported the case as non-serious.
Age: 47.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Rash
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 47 year old male patient who had a medical history of panic disorder with agoraphobia, nicotine dependence, hypertriglyceridemia, obesity, Lichen simplex chronicus, erectile dysfunction, lipomas and Post Traumatic Stress Disorder (PTSD). The patient was being evaluated and managed for PTSD, anxiety disorder and Lichen simplex chronicus. On the 02-Feb-2014, the patient received AFLURIA injection, (batch number R54708) dose 1 via an unknown route in the right arm. On the 03-Feb-2014, the patient developed a rash. Treatment included diphenhydramine 25mg QID (four times a day). Outcome was resolved. Reporter comments: The regulator reported the case as non-serious.
Age: 63.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Neuralgia, Pain in extremity
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 63 year old female patient. On the 03-Oct-2014, the patient received the AFLURIA injection (batch number T50207) via the intramuscular route in the left arm. On the 07-Oct-2014, the patient developed sustained soreness in the arm which was 'nerve related'. Outcome was not recovered.
Age: 63.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Hypoaesthesia, Injection site hypoaesthesia, Injection site pain, Pain in extremity, Product administered at inappropriate site
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 63 year old female patient. On the 03-Oct-2014, the patient received the AFLURIA injection (batch number T50207) via the intramuscular route in the left arm. On the 07-Oct-2014, the patient developed sustained soreness in the arm which was 'nerve related'. Outcome was not recovered.
Age: 63.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: X-ray
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 63 year old female patient. On the 03-Oct-2014, the patient received the AFLURIA injection (batch number T50207) via the intramuscular route in the left arm. On the 07-Oct-2014, the patient developed sustained soreness in the arm which was 'nerve related'. Outcome was not recovered.
Age: 31.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injected limb mobility decreased, Injection site bruising, Injection site pain
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 31 year old female patient who had no medical history and no current illness. On the 03-Jun-2015, the patient received AFLURIA, (batch number T52308) via the intramuscular route in the left arm. On the 03-Jun-2015, the patient developed increased pain at the injection site, an inability to move the arm freely and bruising which extended six inches below the injection site. Outocme was not recovered. Reporter comments: The regulator reported the case as non-serious.
Age: 60.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Myalgia
Clinical narrative: This non-serious health authority report (initial receipt 20-Jul-2015) concerns a 60 year old female patient. On the 24-Sep-2014, the patient received AFLURIA injection (batch number not reported) is an unknown route in the left arm. On the 30-Sep-2014, the patient developed myalgia. Outcome was unknown. Reporter comments: The regulator reported the case as non-serious.
Age: 57.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Asthenia, Musculoskeletal stiffness, Pain
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 57 year old female patient who had no known medical history, no medications at the time of vaccination and no current illness. On the 18-Dec-2014, the patient received AFLURIA (batch number T52508) via the intramuscular route in the left arm. On the 19-Dec-2014, the next day, the patient began to develop symptoms of stiff muscles and pain. Symptoms progressed and became more debilitating over the next few days and then began to resolve in about two weeks. Outcome was recovered.
Age: 55.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Adverse reaction
Clinical narrative: This medically confirmed health authority report (initial receipt 17-Aug-2015) concerns a 55 year old female patient. The patient's medical history was reported as 'antibiotics'. Her current illness included multiple allergies. She had no medications at the time of vaccination. On 15-Oct-2014, the patient received intramuscular AFLURIA injection (batch number: T52708) in the left arm, On 15-Oct-2014, 15 minutes S/P flu injection, the patient developed adverse reactions. The outcome was reported as recovered. Reporter's comments: The health authority assessed the events as non-serious.
Age: 59.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dermatitis contact, Rash, Secretion discharge, Visual impairment
Clinical narrative: This medically confirmed health authority report (initial 17-Aug-2015) concerns a 59 years old female patient. The patient's medical history was reported as 'corn, garlic, milk, cocmyde, and amerchol'. The patient's current illness included corn syrup allergy. She underwent 'cholerectomy' in Jan-2014. She had no other prior medications at the time of vaccination. On 10-Nov-2014, the patient received AFLURIA injection (batch number '53609A'). On 22-Nov-2014, the patient had rash that was oozing on the legs and arms. It appeared to be contact dermatitis but never had this before. She received a steroid injection but it did not help. It flared up if she ate even a small amount of corn syrup or corn starch product. The patient had been monitoring food intake. The rash flared up if she ate out of did not know all the ingredients. her vision also seemed to be affected. She still had very mild rash that was slowly diminishing either by leaving system or trying to avoid corn syrup in foods. The outcome was reported as not recovered.
Age: 59.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dermatitis contact, Rash, Visual impairment
Clinical narrative: This medically confirmed health authority report (initial 17-Aug-2015) concerns a 59 years old female patient. The patient's medical history was reported as 'corn, garlic, milk, cocmyde, and amerchol'. The patient's current illness included corn syrup allergy. She underwent 'cholerectomy' in Jan-2014. She had no other prior medications at the time of vaccination. On 10-Nov-2014, the patient received AFLURIA injection (batch number '53609A'). On 22-Nov-2014, the patient had rash that was oozing on the legs and arms. It appeared to be contact dermatitis but never had this before. She received a steroid injection but it did not help. It flared up if she ate even a small amount of corn syrup or corn starch product. The patient had been monitoring food intake. The rash flared up if she ate out of did not know all the ingredients. her vision also seemed to be affected. She still had very mild rash that was slowly diminishing either by leaving system or trying to avoid corn syrup in foods. The outcome was reported as not recovered.
Age: 11.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Autonomic nervous system imbalance, Blood pressure abnormal, Dizziness, Headache, Heart rate abnormal
Clinical narrative: Case number PHHY2015US139307, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 584654) website on 23 Oct 2015. This report refers to an 11 years old male patient. Medical history and concomitant medications were not reported. The patient was allergic to CEFZIL. The patient was vaccinated with MENVEO (batch number: K018965T) intramuscularly into left arm on 23 Apr 2015. About one hour after vaccination the patient experienced sudden dizziness. Later the patient experienced nausea, headaches, orthostatic intolerance and dysautonomia. Further the patient was diagnosed with POTS (postural orthostatic tachycardia syndrome). The patient went to emergency room due to these events. It was reported that the patient had abnormal blood pressure tests and heart rate while standing. The patient was still trying to treat symptoms with medication. Outcome of the events was reported as not recovered. The case was assessed as non-serious. Causality of the events was not reported. Seriousness assessment of "POTS" was upgraded based on information in the source document. The quality assurance department stated that the reported batch number of MENVEO was not a valid batch number. Hence QA investigation would not be performed for the same. follow-up information from quality assurance department received on 29 Oct 2015: Updated QA comment on batch number of MENVEO.
Age: 11.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Nausea, Orthostatic intolerance, Postural orthostatic tachycardia syndrome
Clinical narrative: Case number PHHY2015US139307, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 584654) website on 23 Oct 2015. This report refers to an 11 years old male patient. Medical history and concomitant medications were not reported. The patient was allergic to CEFZIL. The patient was vaccinated with MENVEO (batch number: K018965T) intramuscularly into left arm on 23 Apr 2015. About one hour after vaccination the patient experienced sudden dizziness. Later the patient experienced nausea, headaches, orthostatic intolerance and dysautonomia. Further the patient was diagnosed with POTS (postural orthostatic tachycardia syndrome). The patient went to emergency room due to these events. It was reported that the patient had abnormal blood pressure tests and heart rate while standing. The patient was still trying to treat symptoms with medication. Outcome of the events was reported as not recovered. The case was assessed as non-serious. Causality of the events was not reported. Seriousness assessment of "POTS" was upgraded based on information in the source document. The quality assurance department stated that the reported batch number of MENVEO was not a valid batch number. Hence QA investigation would not be performed for the same. follow-up information from quality assurance department received on 29 Oct 2015: Updated QA comment on batch number of MENVEO.
Age: 11.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Autonomic nervous system imbalance, Blood pressure orthostatic abnormal, Dizziness, Headache, Heart rate abnormal
Clinical narrative: Case number PHHY2015US139307, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 584654) website on 23 Oct 2015. This report refers to an 11 years old male patient. Medical history and concomitant medications were not reported. The patient was allergic to CEFZIL. The patient was vaccinated with MENVEO (batch number: K018965T) intramuscularly into left arm on 23 Apr 2015. About one hour after vaccination the patient experienced sudden dizziness. Later the patient experienced nausea, headaches, orthostatic intolerance and dysautonomia. Further the patient was diagnosed with POTS (postural orthostatic tachycardia syndrome). The patient went to emergency room due to these events. It was reported that the patient had abnormal blood pressure tests and heart rate while standing. The patient was still trying to treat symptoms with medication. Outcome of the events was reported as not recovered. The case was assessed as non-serious. Causality of the events was not reported. Seriousness assessment of "POTS" was upgraded based on information in the source document. The quality assurance department stated that the reported batch number of MENVEO was not a valid batch number. Hence QA investigation would not be performed for the same. follow-up information from quality assurance department received on 29 Oct 2015: Updated QA comment on batch number of MENVEO.
Age: 37.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injected limb mobility decreased, Musculoskeletal pain, Pain in extremity
Clinical narrative: This medically confirmed health authority report (initial receipt 17-Aug-2015) concerns a 37 year old female patient. The patient had no current illness or medical history. On 01-Oct-2014, the patient received AFLURIA injection (batch number T59707) in the left arm (route SYR). On 01-Oct-2014, the patient experienced severe shoulder pain and was unable to lift her arm over head or lay on her arm. Her arm pain still continued. The outcome was reported as not recovered. Reporter's comments: The health authority assessed the events as non-serious.
Age: 37.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Mobility decreased, Musculoskeletal pain, Pain in extremity
Clinical narrative: This medically confirmed health authority report (initial receipt 17-Aug-2015) concerns a 37 year old female patient. The patient had no current illness or medical history. On 01-Oct-2014, the patient received AFLURIA injection (batch number T59707) in the left arm (route SYR). On 01-Oct-2014, the patient experienced severe shoulder pain and was unable to lift her arm over head or lay on her arm. Her arm pain still continued. The outcome was reported as not recovered. Reporter's comments: The health authority assessed the events as non-serious.
Age: 18.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Urticaria
Clinical narrative: This spontaneous report as received from a physician refers to a 18 year old female patient with no concomitant medications, no pertinent medical history and no drug reactions or allergies. On 19-AUG-2015, the patient was vaccinated with the first dose of GARDASIL 9 0.5 ml, intramuscular in the left arm, lot # K026247 (expiration date was not reported). On 19-AUG-2015 (4 hrs after GARDASIL 9 administration), the patient developed hives. No lab diagnostic studies were performed. The patient sought unspecified medical attention. She was treated with oral BENADRYL and recovered on 20-AUG-2015. At the time of the report the physician has not made a decision whether or not the patient will receive further doses. The causality between hives and GARDASIL 9 was not provided. The adverse event had been reported to Vaccine Adverse Event Reporting System (VAERS). Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: HEP, RV5, HEP, RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse (R.N.) via telephone call on 20-OCT-2015, concerning a 8 week old patient of unknown gender. No concurrent conditions or medical history were reported. On 01-SEP-2015, the patient was vaccinated with an improper stored dose of RECOMBIVAX HB (Lot # L008660 Expiration date: not reported) and with an improper stored dose of ROTATEQ (Lot No. L008031 Expiration date: not reported) (dose, route and anatomical location of administration were not reported). No concomitant therapy was provided. No adverse effects were reported. This is one of several cases from the same reporter. Additional information has been requested.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Arthralgia, Electromyogram, Fatigue, Nuclear magnetic resonance imaging, Pain in extremity
Clinical narrative: I have had all the adverse symptoms since 7/29/15. I have seen numerous doctors and had surgery on my hand. They do not know what to do for me.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Paraesthesia, Peripheral swelling, Ultrasound scan, X-ray
Clinical narrative: I have had all the adverse symptoms since 7/29/15. I have seen numerous doctors and had surgery on my hand. They do not know what to do for me.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Adverse event, Limb operation
Clinical narrative: I have had all the adverse symptoms since 7/29/15. I have seen numerous doctors and had surgery on my hand. They do not know what to do for me.
Age: 61.0
Sex: F
Vaccine: FLUC3, VARZOS
Symptoms: Dermatitis, Musculoskeletal pain, Rash erythematous
Clinical narrative: This spontaneous report was received from a 61 year old female patient who reported for herself. The patient's concurrent conditions and medical history were not reported. On 28-OCT-2015, the patient was vaccinated with ZOSTAVAX (unknown route and strength) lot # L015417 expiry date of August 2016. Concomitant medications were not reported. On 29-OCT-2015, the patient experienced a rash on her back below her right shoulder blade after receiving ZOSTAVAX. The patient sought medical attention for urgent care. The outcome of rash was reported as resolving. Causality assessment was not provided. There was no product quality complaint involved. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: FLUC3, VARZOS
Symptoms: Rash
Clinical narrative: This spontaneous report was received from a 61 year old female patient who reported for herself. The patient's concurrent conditions and medical history were not reported. On 28-OCT-2015, the patient was vaccinated with ZOSTAVAX (unknown route and strength) lot # L015417 expiry date of August 2016. Concomitant medications were not reported. On 29-OCT-2015, the patient experienced a rash on her back below her right shoulder blade after receiving ZOSTAVAX. The patient sought medical attention for urgent care. The outcome of rash was reported as resolving. Causality assessment was not provided. There was no product quality complaint involved. Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Asthma, Condition aggravated, Dyspnoea, Respiratory distress
Clinical narrative: Skeletal and muscular pain, difficulty breathing, shortness of breath requiring nebulized breathing treatment. Severe chills, severe cold feeling, body aches, headache, sore throat, stuffy nose, fatigue - severe symptoms that came on very quickly.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Bone pain, Chills, Dyspnoea, Fatigue, Feeling cold
Clinical narrative: Skeletal and muscular pain, difficulty breathing, shortness of breath requiring nebulized breathing treatment. Severe chills, severe cold feeling, body aches, headache, sore throat, stuffy nose, fatigue - severe symptoms that came on very quickly.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Headache, Mechanical ventilation, Myalgia, Nasal congestion, Oropharyngeal pain
Clinical narrative: Skeletal and muscular pain, difficulty breathing, shortness of breath requiring nebulized breathing treatment. Severe chills, severe cold feeling, body aches, headache, sore throat, stuffy nose, fatigue - severe symptoms that came on very quickly.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pain
Clinical narrative: Skeletal and muscular pain, difficulty breathing, shortness of breath requiring nebulized breathing treatment. Severe chills, severe cold feeling, body aches, headache, sore throat, stuffy nose, fatigue - severe symptoms that came on very quickly.
Age: 61.0
Sex: F
Vaccine: PNC13, VARZOS, PNC13, VARZOS, VARZOS
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Patient experienced redness, tenderness and inflammation at injection site.
Age: 61.0
Sex: F
Vaccine: PNC13, VARZOS, PNC13, VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain
Clinical narrative: Patient experienced redness, tenderness and inflammation at injection site.
Age: 61.0
Sex: F
Vaccine: PNC13, VARZOS, PNC13, VARZOS, VARZOS
Symptoms: Erythema, Herpes zoster, Peripheral swelling
Clinical narrative: Patient experienced redness, tenderness and inflammation at injection site.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Pyrexia
Clinical narrative: High fever over 102 degrees. Per exerted temporal thermometer, multiple readings over 102, with a high of 102.7 before we started ibuprofen.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Rash erythematous, Urticaria
Clinical narrative: Flu vaccine at 5pm sat 10/31. Hives may have appeared earlier, was covered from head to toe with costume at party. No change in diet, detergent, or exposure to anyone with rash. Noticed rash on bilateral arms/legs and some on trunk at 0200. Took OTC Benadryl 25mg 11/1 at 1200 and 2200 with some relief. Morning of 11/2, rash more red and widespread. Rash now extending to fingers, more on trunk, forehead, right eyelid, neck.  Went to Urgent Care. Was seen by Dr. Was given steroid shot and rash decreased in size, gone from face. Now, 11/2 @ 2330, itchy again, rash back on face but now on cheeks, forehead, and bridge of nose. Taking Benadryl now before sleep. Hope this helps in the morning. What to do now, this is miserable.
Age: 47.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Pain on injection, persistent pain since injection.
Age: 49.0
Sex: F
Vaccine: FLU4
Symptoms: Nausea, Tremor, Vision blurred
Clinical narrative: Patient reported nausea, tremors and blurry vision.
Age: 62.0
Sex: M
Vaccine: FLU3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Customer is 62 years old. He received the High Dose Fluzone that is for over age 65 years old.
Age: 29.0
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Pruritus, Rash, Swelling face
Clinical narrative: Left side of face began to swell, itch, and become red (rash like).  From the bottom of chin to cheek bone including lips. 24 hours after shot Face is red with itching and rash has spread to full length of back.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Anaphylactic reaction, Dyspnoea, Feeling hot, Immediate post-injection reaction, Speech disorder
Clinical narrative: 10/5/15 > got Flu vaccine, felt hot immediately then it was difficult to talk and hard to breathe. Epi given and brought to the ER. Prednisone and BENADRYL given in ER. Rx for prednisone 60 mg for 3 days. Seen by Dr in Employee health 10/7/15 and asymptomatic.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Back pain, Dysgeusia, Gait disturbance, Hypoaesthesia, Muscular weakness
Clinical narrative: On 10/14/15 the patient acute unprovoked sharp low back pain. Back pain got progressively worse and began to radiate to lower extremities. By 10/28/15 sx of pain numbness and weakness was experienced in both legs and arms. Pt also reports difficulty walking, metallic taste.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: On 10/14/15 the patient acute unprovoked sharp low back pain. Back pain got progressively worse and began to radiate to lower extremities. By 10/28/15 sx of pain numbness and weakness was experienced in both legs and arms. Pt also reports difficulty walking, metallic taste.
Age: 1.52
Sex: F
Vaccine: DTAP, VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site induration, Injection site mass
Clinical narrative: Pt developed hard lump and redness on her left leg near the area of injection that quadrupled in size throughout the day on Saturday. Taken to the Emergency Room where she was diagnosed with left leg cellulitis.
Age: 61.0
Sex: F
Vaccine: JEV1, TYP
Symptoms: Blood glucose increased, Confusional state, Dizziness, Dysarthria, Fall
Clinical narrative: Verbalized hx of syncope with vaccines. Vaccines administered with pt in semifowlers position. After 15 minutes, pt attempted to sit up. Became dizzy and lost consciousness for 30-60 seconds. Fell off treatment table. Diaphoretic. Slurred speech. Confused.
Age: 61.0
Sex: F
Vaccine: JEV1, TYP
Symptoms: Hyperhidrosis, Loss of consciousness
Clinical narrative: Verbalized hx of syncope with vaccines. Vaccines administered with pt in semifowlers position. After 15 minutes, pt attempted to sit up. Became dizzy and lost consciousness for 30-60 seconds. Fell off treatment table. Diaphoretic. Slurred speech. Confused.
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Chest X-ray normal, Computerised tomogram head normal, Dizziness, Electrocardiogram normal, Headache
Clinical narrative: Dizzy, Nausea, Sweating, Tremors, Headache. IV Fluids; Valium, Reglan, Benadryl.
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Hyperhidrosis, Nausea, Tremor, Troponin normal
Clinical narrative: Dizzy, Nausea, Sweating, Tremors, Headache. IV Fluids; Valium, Reglan, Benadryl.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Eye irritation, Eye pain, Eyelid oedema, Lacrimation increased, Ocular hyperaemia
Clinical narrative: EYES BECAME VERY IRRITATED AND EVENTUALLY BECAME VERY SWOLLEN AND SHUT, ALSO WATERY.
Age: 37.0
Sex: M
Vaccine: FLU4
Symptoms: Rhinitis
Clinical narrative: Nonallergic rhinitis.
Age: 60.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Cellulitis, Peripheral swelling, Skin warm, Urticaria
Clinical narrative: Patients arm had a welt which she was told would be normal, but the swelling continued and progress to and was very warm and swollen. Required an office visit which she was prescribed an antibiotic and prednisone for suspected cellulitis.
Age: 1.02
Sex: M
Vaccine: FLU3, HEPA
Symptoms: Breath holding, Crying, Hypotonia
Clinical narrative: Received Hep A #1 R thigh, cried; Received FLUZONE 0.25 ml IM 6-35 mo cried - held breath - went limp; Baby in mom's arm, mom ran out of room for addenenal abreaction.
Age: 64.0
Sex: M
Vaccine: FLU4
Symptoms: Musculoskeletal pain, Musculoskeletal stiffness, Myalgia, Pain
Clinical narrative: Patient describes a stiffness/soreness (similar to muscle strain) from collar bone area to upper shoulder. Patient describes soreness especially with stretching arm behind his back.
Age: 75.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Chest pain, Dizziness, Dyspnoea, Nausea
Clinical narrative: Dizziness, weakness, stabbing pain in the whole body, difficulty breathing, pain on the chest.
Age: 75.0
Sex: F
Vaccine: FLU4
Symptoms: Pain
Clinical narrative: Dizziness, weakness, stabbing pain in the whole body, difficulty breathing, pain on the chest.
Age: 29.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Expired product administered, Tuberculin test
Clinical narrative: This non-serious medically confirmed spontaneous report (initial receipt 27-MAY-2015) concerns a 29 year-old non-pregnant female patient. The patient had medical history of screening for pulmonary TB, vaccine against tetanus and flue vaccine. On 27-MAY-2015, the patient received one dose of expired AFLURIA (batch number T57105) via the intramuscular route. On the same day, the patient also received BOOSTRIX (batch number  not provided) on another arm, and TB skin test (batch number not provided) on the same arm as the AFLURIA injection. The outcome was not provided. Reporters comments: The reporter insisted that no patient harm occurred.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Blepharospasm, Headache, Insomnia, Joint stiffness
Clinical narrative: Flu vaccine 10/12/15; insomnia; headaches; sore throat; night sweats; rash; low grade fever; L eye twitching; joint pain. Day 16 her only persistence is joint stiffness and L eye twitching.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Night sweats, Oropharyngeal pain, Pyrexia, Rash
Clinical narrative: Flu vaccine 10/12/15; insomnia; headaches; sore throat; night sweats; rash; low grade fever; L eye twitching; joint pain. Day 16 her only persistence is joint stiffness and L eye twitching.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Injection site erythema, Injection site pruritus, Nausea, Pruritus
Clinical narrative: 10/12/15 flu vaccine giving lightheaded after injection and queasy. Rash on her arm. Diffuse itchiness to her chest and neck. 10/16/15> seen in employee health, injection site red 20 mm and itching. BENADRYL, 10/21/15 > seen by dr; continues BENADRYL so needed; avoid flu vaccine.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: 10/12/15 flu vaccine giving lightheaded after injection and queasy. Rash on her arm. Diffuse itchiness to her chest and neck. 10/16/15> seen in employee health, injection site red 20 mm and itching. BENADRYL, 10/21/15 > seen by dr; continues BENADRYL so needed; avoid flu vaccine.
Age: 7.0
Sex: M
Vaccine: FLU4
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Arm redness and swelling from shoulder down to elbow. Patient advised to use cold compress, give oral Claritin and local anti-itch cream.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain
Clinical narrative: This medically confirmed health authority report (initial receipt 14-Aug-2015) concerns a 26-year old female patient. Last year, the patient received FLUVIRIN and had no complaints. On 13-AUg-2015, the patient received AFLURIA injection (batch number: U55806) at 0.5 ml annually in an unspecified arm. On 13-Aug-2015. the injection was immediately painful upon administration. As the day progressed, the patient could barely lift her arm that received the shot. This was the first time the patient had a reaction like this. The patient developed severe soreness at the injection site. The outcome was reported as unknown. Reporter's comments: The reporter assessed the events as non-serious.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: None.
Age: 44.0
Sex: F
Vaccine: FLUX
Symptoms: Pain, Pain in extremity, Tenderness
Clinical narrative: Persistent pain in arm unlike normal vaccine administration.  Painful to use arm in certain directions and to lay upon. Now taking Motrin.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: 60 year old female received the HIGH Dose Fluzone Vaccine for people >65 years old.
Age: 34.0
Sex: M
Vaccine: ANTH
Symptoms: Rash generalised, Urticaria
Clinical narrative: Hive and Rashes all over body.
Age: 56.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Cellulitis, Headache, Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: Vaccine administered in LA, SQ on 10/29/15 at 16:15.  Patient noted itching 24 hrs later and rounded localized large erythemic lump at injection site.  Noted headache, but may or may not be related.  No fever, SOB or other symptoms.  Patient noted throbbing of left arm, warm to touch until Rx of Keflex given for cellulitits diagnosed by NP (5 mg BID x 10 days).
Age: 56.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain in extremity, Skin warm
Clinical narrative: Vaccine administered in LA, SQ on 10/29/15 at 16:15.  Patient noted itching 24 hrs later and rounded localized large erythemic lump at injection site.  Noted headache, but may or may not be related.  No fever, SOB or other symptoms.  Patient noted throbbing of left arm, warm to touch until Rx of Keflex given for cellulitits diagnosed by NP (5 mg BID x 10 days).
Age: 56.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Cellulitis, Headache, Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: Vaccine administered in LA, SQ, on 10/29/15 at 1615. Patient noted itching 24 hrs later, and round localized large erythema with lump at injection site. Noted headache, but may or may not be related. No fever, SOB, or other symptoms. Patient noted throbbing of left arm, warm to touch until Rx of KEFLEX given for cellulitis diagnosed by NP 500mg BID x 10 days.
Age: 56.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain in extremity, Skin warm
Clinical narrative: Vaccine administered in LA, SQ, on 10/29/15 at 1615. Patient noted itching 24 hrs later, and round localized large erythema with lump at injection site. Noted headache, but may or may not be related. No fever, SOB, or other symptoms. Patient noted throbbing of left arm, warm to touch until Rx of KEFLEX given for cellulitis diagnosed by NP 500mg BID x 10 days.
Age: 8.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling, warmth and pain over left deltoid/shoulder.
Age: 28.0
Sex: M
Vaccine: FLU4
Symptoms: Mobility decreased, Musculoskeletal pain
Clinical narrative: Patient reported pain in shoulder and reduction of movement after injection.
Age: 72.0
Sex: F
Vaccine: FLU4
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: Pt reported event on 10-30-15. The patient stated she got a Flu shot on 10/27/15 around 1400. She stated the next morning she woke up with diarrhea and stomach pain. She stated the S/S lasted throughout the day and resolved on 10-28-15 in the evening.
Age: 34.0
Sex: F
Vaccine: FLUC3
Symptoms: Chest discomfort, Erythema multiforme, Pruritus, Rash, Urticaria
Clinical narrative: Patient is a nurse identified sxs of potential allergic reaction and treated herself with diphenhydramine later that evening. Symptoms subsided quickly. Rash, Erythema Multiforme, Urticaria Pruritus and Chest tightness.
Sex: U
Vaccine: FLUX, VARZOS
Symptoms: Pruritus
Clinical narrative: This medically confirmed spontaneous report (initial receipt 22-Jul-2015) concerns a patient (demography not reported). On an unspecified date, the patient received unspecified flu vaccination (batch number not reported) and ZOSTAVAX (batch number not reported) concomitantly. On an unspecified date, the patient experienced local itching. No further information was provided. The outcome was not reported.
Sex: U
Vaccine: FLUX, VARZOS
Symptoms: Pruritus
Clinical narrative: This medically confirmed spontaneous report (initial receipt 22-Jul-2015) concerns a patient (demography not reported). On an unspecified date, the patient received unspecified flu vaccination (manufacturer and batch number not reported) and ZOSTAVAX (batch number not reported) concomitantly. ZOSTAVAX was given to prevent shingles. On an unspecified date, the patient developed pruritus that lasted between 2 and 3 months. No further information was provided. The outcome was not reported.
Sex: U
Vaccine: FLUX
Symptoms: Peripheral swelling
Clinical narrative: This non-serious medically confirmed spontaneous report (initial receipt 03-Jun-2015) concerns an unspecified patient. On an unspecified date, the patient received an unspecified Influenza vaccine (manufacturer and batch number not provided). On an unspecified date, following the administration of an unspecified Flu vaccine, the patient experienced a swollen arm due to its egg content. The outcome was not reported.
Age: 68.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Eyelid rash, Rash
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Apr-2015) concerns a 68 year old female patient who had a thiomersal allergy and hypertension. Concomitant medications included lisinopril, zolpidem and nitroglycerin ointment. On the 08-Jan-2015, the patient received AFLURIA injection (batch number (TS0007) via the intramuscular route in the left arm. She had also received a PNEUMOVAX immunisation (batch number not reported) at her doctor's office before going into the pharmacy. On the 09-Jan-2015, the patient developed a rash on her face and eyes. There was no irritation at the injection site. The patient filled a prescription for fluorometholone ointment from an ophthalmologist. Outcome was unknown. Reporter comments: The regulator reported the case as non-serious and reported that the patient attended the Emergency Room.
Age: 16.0
Sex: U
Vaccine: FLU3
Symptoms: Wrong drug administered
Clinical narrative: This non-serious medically confirmed health authority report (initial receipt 20-Jul-2015) concerns a 16 year old patient. On the 05-Nov-2014, the patient received AFLURIA injection (batch number not reported) in the left arm. The patient was given the Influenza vaccine accidentally instead of the PPD (purified protein derivative) in the left forearm. Outcome was unknown. Reporter comments: The regulator reported the case as non-serious.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site haemorrhage, Injection site swelling, Nausea
Clinical narrative: This medically confirmed spontaneous report (initial receipt 26-Aug-2015) concerns a 63 year-old female patient who had no history of bleeding and was not on any blood thinning medications. On 26-Aug-2015 at 11:00 AM, the patient received AFLURIA (batch number U54806) 0.5mL via the intramuscular route on the right deltoid/arm. AFLURIA was stored correctly. On 26-Aug-2015 at 11:00 am, the patient experienced profuse bleeding at the injection site after the AFLURIA was administered and the PFS was pulled out of the right deltoid. Some blood spilled onto the floor. After the bandage was placed onto the injections site on the right arm (site of injection) started to swell and became swollen. Patient then became nauseated. Ice pack was placed onto the swollen arm for fifteen minutes and the patient rested for the duration until the swelling subsided. The bleeding discontinued upon bandage placement. The outcome was recovered on 26-Aug-2015. Reporter's comments: The reporter insisted that the vaccine was administered properly into the muscle.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous medically confirmed report (initial receipt 28-Aug-2015) concerns a 32 year old female patient. The patient had no medical history. On 28-Aug-2015, the patient inadvertently received an intramuscular dose of expired AFLURIA (batch number 10249211A, expiry date: 30-Jun-2015) at 0.5 ml once. No adverse reaction occurred since administration. The outcome was reported as recovered. Reporter's comments: The reporter assessed the event as non-serious. Follow-up (08-Sep-2015): The spelling of the reporter's name updated. No new information.
Sex: U
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: This non-serious consumer report (initial; receipt 24-Jul-2015) concerns an unspecified patient. On an unspecified date, the patient received CSL Bio/Therapies influenza vaccine (batch number not provided). On an unspecified date, the patient developed an unspecified reaction site of hives. Outcome was not reported.
Age: 69.0
Sex: M
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injection site swelling
Clinical narrative: This medically confirmed health authority report (initial receipt 11-May-2015) concerns a 69 year-old male patient. On 18-Sep-2014, the patient received AFLURIA injection (batch number: T50607) in the left arm (site unknown). On 19-Sep-2014, the patient experienced swelling of left upper arm immediately post vaccination. The outcome was reported as recovered. Reporter comments: The health authority assessed the events as non-serious.
Sex: F
Vaccine: FLUX
Symptoms: Injection site swelling
Clinical narrative: This medically confirmed spontaneous report (initial receipt 18-May-2015) concerns a female patient. The patient had drug reactions/allergies to sulfa. On an unspecified date, the patient received unknown influenza virus vaccine (batch number not reported). On an unspecified date, the patient developed localised swelling at the injection site. The outcome was reported as recovered. Linked case: 2015051263 (same patient).
Age: 4.0
Sex: M
Vaccine: DTAP, HEPA, MMRV
Symptoms: Vaccination error
Clinical narrative: Found the vaccine error in log book.
Age: 93.0
Sex: F
Vaccine: FLU3
Symptoms: Purpura
Clinical narrative: Purpura aprox. 5 inches below injection site.
Age: 63.0
Sex: M
Vaccine: PPV
Symptoms: Mobility decreased, Pain in extremity, Pyrexia, Sleep disorder
Clinical narrative: Extreme pulsing pain, so severe he could not move his arm.  He also had intermittent fevers through the night.  He was not able to sleep due to the pain. He tried hot packs, cold packs, Tylenol with codeine, and naproxen with no relief in pain.
Age: 54.0
Sex: M
Vaccine: FLUX
Symptoms: Eye pruritus, Pruritus, Pyrexia, Rash
Clinical narrative: Rash across upper chest which spread by evening & continued the next day with itchy eyes & skin accompanied with low grade fever of 100. On 11/1-11/3/15 taking antihistamine.
Age: 23.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Pt. reports that one hour after vaccine administration swelling and pain occurred to site of injection and has continued through day of reporting to Co Health Department 10/26/15.  Reports that she has not done any follow up with provider, no analgesics, no cold pack or warm pack to comfort site or symptoms.
Age: 74.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: PATIENT REPORTS PAIN IN HER RIGHT ARM FROM VACCINATION THAT HAS NOT RESOLVED. SHE HAS NOT SOUGHT MEDICAL TREATMENT AT THIS TIME AND REFUSED THE PHARMACY TO CALL HER PHYSICIAN.
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Dizziness, Injection site erythema, Injection site hyperaesthesia, Injection site induration, Injection site mass
Clinical narrative: The injection site was hot to touch and a dime sized hard lump formed when I woke up about 11 AM Friday. I looked up reactions and thought it just needed more time to go away. It progressed and Saturday (10/31) my upper right arm was sore, the lump had grown to 2 inches in diameter, it was still hot, and it hurts to wear clothing (I can feel the rubbing on the injection site). I took naproxen and Benadryl to hopefully help. Sunday (11/01) it had gotten bigger again but not as red, I thought it was improving. I had bouts of nausea and was lightheaded off and on and slept for 6 hours later in the day. Monday I was seen by my doctor. She didn't know anything about reactions, she said she hadn't come across one before and just to take naproxen regularly along with Benadryl and give it another week to go away. My white blood cell count was taken but she will not dispense antibiotics or other meds until the blood work comes back. It is Tuesday (11/03), 5 days after my shot, and the injection site is still sensitive to clothing, the red area is about 3 inches in diameter, the hard lump is about an inch in diameter, and it is still hot to touch.
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site warmth, Nausea, Pain in extremity, White blood cell count
Clinical narrative: The injection site was hot to touch and a dime sized hard lump formed when I woke up about 11 AM Friday. I looked up reactions and thought it just needed more time to go away. It progressed and Saturday (10/31) my upper right arm was sore, the lump had grown to 2 inches in diameter, it was still hot, and it hurts to wear clothing (I can feel the rubbing on the injection site). I took naproxen and Benadryl to hopefully help. Sunday (11/01) it had gotten bigger again but not as red, I thought it was improving. I had bouts of nausea and was lightheaded off and on and slept for 6 hours later in the day. Monday I was seen by my doctor. She didn't know anything about reactions, she said she hadn't come across one before and just to take naproxen regularly along with Benadryl and give it another week to go away. My white blood cell count was taken but she will not dispense antibiotics or other meds until the blood work comes back. It is Tuesday (11/03), 5 days after my shot, and the injection site is still sensitive to clothing, the red area is about 3 inches in diameter, the hard lump is about an inch in diameter, and it is still hot to touch.
Age: 11.0
Sex: M
Vaccine: FLU3, MNQ, TDAP
Symptoms: Injection site erythema
Clinical narrative: Based on a picture, large, round, erythematous region near right deltoid muscle. Lasted 48-72 hours and appeared within 24 hours.
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Arthralgia, Fatigue, Headache, Injection site erythema, Injection site pain
Clinical narrative: Redness, swelling, and pain at injection site beginning 10/24/2015 AM, and completely resolved by 10/28/2015 PM. Headache, aching joints, and fatigue began 10/24/2015 PM, also completely resolved by 10/28/2015 PM.
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site swelling
Clinical narrative: Redness, swelling, and pain at injection site beginning 10/24/2015 AM, and completely resolved by 10/28/2015 PM. Headache, aching joints, and fatigue began 10/24/2015 PM, also completely resolved by 10/28/2015 PM.
Age: 73.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Body temperature increased, Lip swelling, Swollen tongue
Clinical narrative: Patient reported swollen lower lip and tongue. Denied difficulty breathing. T 99.1. At 6:18 patient said tongue felt normal, right lower lip remained slightly swollen. Temp 98.8 with Tylenol. Difficulty breathing denied.
Age: 65.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Injection site erythema, Injection site swelling, Skin irritation
Clinical narrative: Patient is complaining of irritation on her arm. Redness and swelling at the injection site.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: By end of day pt c/o pain in (L) brachium which continued post injection which continues to present date.
Age: 7.0
Sex: M
Vaccine: TDAP
Symptoms: Malaise, Pyrexia, Retching, Sleep disorder, Vomiting
Clinical narrative: Mom reports that client woke up in the middle of the night not feeling well and with a fever of 102F. Per mom, fever broke at around 7AM, then client vomited/"retched" at around 10AM. Mom instructed to continue to monitor and call family doctor if symptoms worsen regardless of whether they are side effects or a separate infection/illness.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Injected limb mobility decreased, Injection site pain, Mobility decreased
Clinical narrative: Upper arm hurting where shot was given. Unable to move arm in any motion. Hard to dress and reach. Am taking pain meds every day (are for back pain). Having hard time moving arm. Will see doctor tomorrow (11/04/2015).
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Rash over torso, ears, head, neck.